DOXIMITY INC-CLASS A (DOCS)
US26622P1075 - Common Stock
Is NYSE:DOCS a Suitable Choice for Quality Investing?
This article explores why quality investors may have a look at DOXIMITY INC-CLASS A (NYSE:DOCS)
Notable Friday Option Activity: AAOI, DOCS, INOD
Why Doximity Stock Is Skyrocketing Today
The market loved what it saw from Doximity's second-quarter earnings.
Doximity (DOCS) Stock Trades Up, Here Is Why
Shares of healthcare professional network Doximity (NYSE:DOCS) jumped 48.2% in the afternoon session after the company reported impressive third-quarter earnings, which blew past analysts' revenue, EPS, and EBITDA expectations.
Get insights into the top gainers and losers of Friday's pre-market session.
Get insights into the top gainers and losers of Friday's pre-market session.
Which stocks are moving after the closing bell on Thursday?
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Doximity (NYSE:DOCS) Delivers Impressive Q3, Stock Jumps 33.6%
Healthcare professional network Doximity (NYSE:DOCS) reported revenue ahead of Wall Street’s expectations in Q3 CY2024, with sales up 20.4% year on year to $136.8 million. On top of that, next quarter’s revenue guidance ($152.5 million at the midpoint) was surprisingly good and 8.5% above what analysts were expecting. Its non-GAAP profit of $0.30 per share was also 17% above analysts’ consensus estimates.
Doximity Announces Fiscal 2025 Second Quarter Financial Results
Doximity (DOCS) Reports Earnings Tomorrow: What To Expect
Healthcare professional network Doximity (NYSE:DOCS) will be announcing earnings results tomorrow after market close. Here’s what to expect.
Doximity to Present at the Jefferies London Healthcare Conference
Noteworthy Monday Option Activity: VZ, DOCS, CMA
Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024
DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS
DOXIMITY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS
Should You Buy This Stock After It Skyrocketed by 33%?
It's a welcome sight for shareholders who haven't had much to rejoice about lately.